Accuray (ARAY) Current Deferred Revenue (2011 - 2026)
Accuray's (ARAY) quarterly Current Deferred Revenue came in at $78.9 million in Q1 2026, down 3.44% year-on-year from $81.8 million in Q1 2025, and little changed quarter-over-quarter from $79.0 million in Q4 2025.
Accuray (ARAY) Current Deferred Revenue (2011 - 2026) Analysis & Trends
Accuray's Current Deferred Revenue history runs 16 years deep, the most recent figure standing at $78.9 million for Q1 2026.
- On a quarterly basis, Current Deferred Revenue fell 3.44% year-over-year to $78.9 million in Q1 2026; TTM through Mar 2026 was $78.9 million, a 3.44% decrease from a year earlier, with the FY2025 full-year figure at $82.3 million, up 14.87% from the prior year.
- Current Deferred Revenue was little changed at $78.9 million in Q1 2026 per ARAY's latest filing, from $79.0 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $82.3 million in Q2 2025 and bottomed at $69.9 million in Q3 2022.
- The 5-year median for Current Deferred Revenue is $75.4 million (2022), against an average of $75.9 million.
- Across the five-year window, Current Deferred Revenue dropped 11.33% in 2022 and rose 14.87% in 2025, its largest moves.
- Year by year, Current Deferred Revenue stood at $72.7 million in 2022, then grew by 6.51% to $77.4 million in 2023, then declined by 6.87% to $72.1 million in 2024, then climbed by 9.56% to $79.0 million in 2025, then retreated by 0.04% to $78.9 million in 2026.
- Per Business Quant, the three latest ARAY Current Deferred Revenue figures stand at $78.9 million (Q1 2026), $79.0 million (Q4 2025), and $79.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Accuray | 29,832.96 | -38.50 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.94 Mn |
| Dec 31, 2025 | 78.98 Mn |
| Sep 30, 2025 | 79.63 Mn |
| Jun 30, 2025 | 82.31 Mn |
| Mar 31, 2025 | 81.75 Mn |
| Dec 31, 2024 | 72.09 Mn |
| Sep 30, 2024 | 81.32 Mn |
| Jun 30, 2024 | 71.65 Mn |
| Mar 31, 2024 | 73.73 Mn |
| Dec 31, 2023 | 77.41 Mn |
| Sep 30, 2023 | 71.76 Mn |
| Jun 30, 2023 | 72.19 Mn |
| Mar 31, 2023 | 73.14 Mn |
| Dec 31, 2022 | 72.68 Mn |
| Sep 30, 2022 | 69.95 Mn |
| Jun 30, 2022 | 75.38 Mn |
| Mar 31, 2022 | 76.73 Mn |
| Dec 31, 2021 | 76.59 Mn |
| Sep 30, 2021 | 78.89 Mn |
| Jun 30, 2021 | 81.66 Mn |